{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:46:21Z","timestamp":1782747981818,"version":"3.54.5"},"reference-count":33,"publisher":"Cambridge University Press (CUP)","issue":"S4","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":11278,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[1984,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alteration of membrane fluidity and anomalies of membrane structural proteins have been suspected in Friedreich's ataxia. Plasma lecithinxholesterol acyltransferase (LCAT) activity is also lowered in this disease, presumably because of a substrate effect. The membrane-stabilizing effect of cholesteryl sulfate (CS) and its inhibitory effect on LCAT activity prompted us to measure this substance in the plasma of Friedreich's ataxia patients as well as in normal subjects and in patients with Charlevoix-Saguenay disease. Plasma cholesteryl sulfate concentrations were significantly higher in Friedreich's ataxia, with levels above the upper limit of normal in nearly half of the cases. This increase was unrelated to age, sex or plasma cholesterol levels, but closely associated with the severity of the disease and thus considered to be secondary. A similar phenomenon (except the association with severity) was observed in Charlevoix-Saguenay ataxia. Levels also tended to be higher in first-degree relatives of Friedreich cases. The significance of these findings is discussed in the light of recent knowledge and experimental data obtained in this laboratory on rats made deficient in essential fatty acids. The highest concentrations of CS observed in Friedreich's ataxia (1097 \u00b5-g\/dL, 6 times the normal mean) was only 25% as high as the concentrations reported to inhibit LCAT activity.<\/jats:p>","DOI":"10.1017\/s0317167100035198","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T11:36:16Z","timestamp":1469705776000},"page":"631-636","source":"Crossref","is-referenced-by-count":5,"title":["Plasma Cholesteryl Sulfate in Friedreich's ataxia"],"prefix":"10.1017","volume":"11","author":[{"given":"A.C.","family":"Nestruck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Davignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100035198_ref032","doi-asserted-by":"publisher","DOI":"10.1042\/bj0900374"},{"key":"S0317167100035198_ref029","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a131333"},{"key":"S0317167100035198_ref027","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.12.7266"},{"key":"S0317167100035198_ref024","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1983.10719909"},{"key":"S0317167100035198_ref023","doi-asserted-by":"publisher","DOI":"10.1139\/o81-083"},{"key":"S0317167100035198_ref022","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100023015"},{"key":"S0317167100035198_ref021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0317167100024951","article-title":"Plasma lipids and lipoproteins in Friedreich\u2019s ataxia and familial spastic ataxia \u2014 evidence for an abnormal composition of high density lipoproteins","volume":"5","author":"Huang","year":"1978","journal-title":"Can J Neurol Sci"},{"key":"S0317167100035198_ref020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0317167100024859","article-title":"Familial hyperbilirubinemia in Friedreich\u2019s ataxia","volume":"5","author":"Hamel","year":"1978","journal-title":"Can J Neurol Sci"},{"key":"S0317167100035198_ref017","doi-asserted-by":"publisher","DOI":"10.1007\/BF00445900"},{"key":"S0317167100035198_ref016","doi-asserted-by":"publisher","DOI":"10.1126\/science.6945674"},{"key":"S0317167100035198_ref015","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110153"},{"key":"S0317167100035198_ref014","article-title":"Nouvelle approche d\u2019isolement et de mesuredu cholest\u00e9ryl sulfate (CS) dans le plasma humain","author":"Eid","year":"1981","journal-title":"Thesis for M.Sc. in Clinical Sciences, Faculty of Graduate Studies"},{"key":"S0317167100035198_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2728(75)90195-4"},{"key":"S0317167100035198_ref011","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100119808"},{"key":"S0317167100035198_ref010","doi-asserted-by":"publisher","DOI":"10.1021\/bi00839a014"},{"key":"S0317167100035198_ref009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0317167100024793","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"5","author":"Bouchard","year":"1978","journal-title":"Can J Neurol Sci"},{"key":"S0317167100035198_ref007","doi-asserted-by":"publisher","DOI":"10.1017\/S031716710004395X"},{"key":"S0317167100035198_ref006","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-1-220"},{"key":"S0317167100035198_ref005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"key":"S0317167100035198_ref004","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100025634"},{"key":"S0317167100035198_ref003","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100025646"},{"key":"S0317167100035198_ref002","first-page":"211","article-title":"The formation of cholesteryl sulphate by androstenolonesulphotransferase","volume":"137","author":"Banerjee","year":"1967","journal-title":"BiochimBiophysActa"},{"key":"S0317167100035198_ref001","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"key":"S0317167100035198_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(76)90170-3"},{"key":"S0317167100035198_ref030","doi-asserted-by":"publisher","DOI":"10.1017\/S031716710002285X"},{"key":"S0317167100035198_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(76)90101-X"},{"key":"S0317167100035198_ref028","doi-asserted-by":"publisher","DOI":"10.1139\/o82-068"},{"key":"S0317167100035198_ref019","first-page":"604","volume-title":"The metabolic basis of inherited disease","author":"Fredrickson","year":"1978"},{"key":"S0317167100035198_ref008","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(74)90174-6"},{"key":"S0317167100035198_ref031","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/clinchem\/21.13.1983","article-title":"Fasterenzymatic procedure for serum triglycerides","volume":"21","author":"Sampson","year":"1975","journal-title":"Clin Chem"},{"key":"S0317167100035198_ref033","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(70)90382-7"},{"key":"S0317167100035198_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(79)90094-3"},{"key":"S0317167100035198_ref012","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/56.3.463"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100035198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T01:29:34Z","timestamp":1656898174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100035198\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,11]]},"references-count":33,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[1984,11]]}},"alternative-id":["S0317167100035198"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100035198","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,11]]}}}